Humana reports fourth quarter and full year 2019
A weak finish to an eventful yearQ4, October–December 2019 · Operating revenue was SEK 1,912m (1,700), an increase of 12%, of which organic growth was 0.7%. · Operating profit was SEK 71m (82), a decrease of 13%. The profit was affected by integration costs of SEK -6m (-) for Coronaria Hoiva. The effects of IFRS 16, the new accounting standard that came into effect on 1 January 2019, on operating profit amounted to SEK 16m (-). · Net profit after tax for the period amounted to SEK 18m (51). · Earnings per share for the period before and after dilution amounted to SEK 0.35 (0.